遗传性血栓性作为COVID-19中严重疾病的可能风险因素:一个病例系列
Jonathan Tse1, Julita Gongolli2, Joseph A Prahlow3
1Western Michigan University Homer Stryker MD School of Medicine, 300 Portage St. Kalamazoo, Kalamazoo, MI, 49007, USA. Jonathan.tse@wmed.edu.
Forensic science, medicine, and pathology
|September 27, 2024
概括
遗传性血栓性病可能会增加COVID-19患者致命血栓性并发症的风险. 这些遗传因素与COVID-19感染相结合,可能导致肺栓塞和心脏病发作等严重后果.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 传染性疾病 传染性疾病
背景情况:
- 严重的COVID-19与各种风险因素有关,高凝血能力是一个重要的,但往往被低估的贡献者.
- COVID-19感染本身可以诱导高凝血状态,增加血块发生的可能性.
研究的目的:
- 调查遗传性血栓性病作为COVID-19患者严重血栓性并发症的风险因素的潜在作用.
- 探索一种假设,即患有遗传性凝血障碍的个体在感染SARS-CoV-2时可能面临更高的风险.
主要方法:
- 本研究介绍了一个病例报告,详细介绍了COVID-19患者的两个致命结果.
- 遗传分析在两例病例中都发现了先前未被诊断的遗传性血栓塞病,这可能导致了他们的死亡率.
主要成果:
- 第一个患者死于肺血栓栓塞的二次性深静脉血栓,与MTHFR C667T和PAI-1 4G/5G突变相关.
- 第二名患者经历了由于冠状动脉血栓形成的急性心肌梗塞,与MTHFR A1298C和同卵性PAI-1 4G/5G突变有关.
- 在这两种情况下,COVID-19感染是导致死亡的因素.
结论:
- 这些病例表明遗传性血栓和COVID-19之间的潜在协同效应,导致致命的血栓事件.
- 需要进一步的研究,以了解遗传凝血倾向和SARS-CoV-2感染的相互作用,潜在地识别高风险患者群体并告知临床管理.
更多相关视频
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
636
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
636
01:24Disorders of Hemostasis
738
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
738
01:30Venous Thrombosis I: Introduction
3
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
3
01:29Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
01:20Extrinsic and Intrinsic Pathways of Hemostasis
6.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.3K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
3
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
3